Melanoma/Skin Cancer

Top Story

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients
June 26, 2017

Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today.

The venture is intended to further progress in cancer prevention, detection, treatment and care, while reducing disparities in patient outcomes.

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist, also will serve as…
In the Journals

Histopathologic features of melanoma in difficult-to-diagnose lesions varied in accuracy

June 19, 2017
While certain histopathologic features of difficult-to-diagnose lesions significantly influenced the final diagnosis of melanoma, some features varied in accuracy and…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” HemOnc Today
CME

Toward Precision Medicine for Advanced Melanoma Management: Making the Most of Targeted Agents

This activity is supported by an educational grant from Novartis.

The identification and utilization of melanoma specific biomarkers continues to be of importance for diagnosis and…
More »
Video
Meeting News

VIDEO: Research has made ‘major strides’ in answering key questions in immuno-oncology

June 5, 2017
More »
Featured

CME

Immune Checkpoint Inhibition for Melanoma Management: When, What, How, and in Whom?

This activity is supported by educational grants from Bristol-Myers Squibb and Merck & Co., Inc.

It is estimated that 76,380 new cases of melanoma will be diagnosed in the United Stated in 2017, with approximately…
More »

Biden Cancer Initiative seeks to inject urgency into cancer research, foster hope for patients

June 26, 2017
Former Vice President Joe Biden and his wife, Jill Biden, PhD, launched the Biden Cancer Initiative today. The venture is intended to further…

Geneticist to lead Vanderbilt cancer center’s health disparities program

June 19, 2017
Tuya Pal, MD, has been appointed associate director of cancer health disparities at Vanderbilt-Ingram Cancer Center. Pal, a clinical geneticist…

In the Journals

Histopathologic features of melanoma in difficult-to-diagnose lesions varied in accuracy

June 19, 2017
While certain histopathologic features of difficult-to-diagnose lesions significantly influenced the final diagnosis of melanoma, some features…

10 highlights from the ASCO Annual Meeting

June 16, 2017
This year’s ASCO Annual Meeting, held June 2-6 in Chicago, featured the theme “Making a Difference in Cancer Care With You.” …

In the Journals

Factors in early adolescence associated with mole-prone phenotype later

June 15, 2017
Researchers found clinical features in early adolescence that were associated with mole-prone phenotype in later adolescence, which may help identify…

Oral contraceptive use does not increase long-term cancer risk

June 14, 2017
Women who used oral contraceptives did not demonstrate increased long-term cancer risk, according to results of the Royal College of General…

In the Journals

PCP-based skin cancer screening feasible

June 13, 2017
Primary care-based skin cancer training and screening is feasible, and may improve primary care physician diagnostic accuracy, according to recently…

Meeting NewsVideo

VIDEO: Visiting expert program helps community providers learn about immuno-oncology

June 12, 2017
CHICAGO — Jarushka Naidoo, MBBCh, spoke with HemOnc Today at the ASCO Annual Meeting about the Institute for Clinical Immuno-Oncology. The…

In the Journals

Keytruda treatment may be associated with eruptive keratoacanthomas

June 12, 2017
Keytruda therapy was associated with eruptive keratoacanthomas in three patients with metastatic squamous cell carcinoma or metastatic melanoma…

FDA News

FDA rejects Coherus application for proposed biosimilar to Neulasta

June 12, 2017
The FDA denied approval of Coherus BioSciences’ biologics license application for CHS-1701, a proposed biosimilar for pegfilgrastim. Like…

More Headlines »
Advertisement
Advertisement